197 related articles for article (PubMed ID: 33382687)
1. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
[TBL] [Abstract][Full Text] [Related]
2. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
Front Immunol; 2020; 11():610300. PubMed ID: 33391280
[TBL] [Abstract][Full Text] [Related]
3. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
Front Immunol; 2021; 12():627548. PubMed ID: 33777012
[TBL] [Abstract][Full Text] [Related]
4. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
6. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.
Tang G; Huang M; Luo Y; Liu W; Lin Q; Mao L; Wu S; Xiong Z; Hou H; Sun Z; Wang F
Front Immunol; 2021; 12():697622. PubMed ID: 34777333
[TBL] [Abstract][Full Text] [Related]
7. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
Payen D; Cravat M; Maadadi H; Didelot C; Prosic L; Dupuis C; Losser MR; De Carvalho Bittencourt M
Front Immunol; 2020; 11():580250. PubMed ID: 33178207
[TBL] [Abstract][Full Text] [Related]
8. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
[TBL] [Abstract][Full Text] [Related]
9. Impaired function and delayed regeneration of dendritic cells in COVID-19.
Winheim E; Rinke L; Lutz K; Reischer A; Leutbecher A; Wolfram L; Rausch L; Kranich J; Wratil PR; Huber JE; Baumjohann D; Rothenfusser S; Schubert B; Hilgendorff A; Hellmuth JC; Scherer C; Muenchhoff M; von Bergwelt-Baildon M; Stark K; Straub T; Brocker T; Keppler OT; Subklewe M; Krug AB
PLoS Pathog; 2021 Oct; 17(10):e1009742. PubMed ID: 34614036
[TBL] [Abstract][Full Text] [Related]
10. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
Front Immunol; 2021; 12():691725. PubMed ID: 34248984
[TBL] [Abstract][Full Text] [Related]
11. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
Shi W; Liu X; Cao Q; Ma P; Le W; Xie L; Ye J; Wen W; Tang H; Su W; Zheng Y; Liu Y
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L84-L98. PubMed ID: 33146564
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
[TBL] [Abstract][Full Text] [Related]
13. Unique immunological profile in patients with COVID-19.
Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
[TBL] [Abstract][Full Text] [Related]
14. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.
Zenarruzabeitia O; Astarloa-Pando G; Terrén I; Orrantia A; Pérez-Garay R; Seijas-Betolaza I; Nieto-Arana J; Imaz-Ayo N; Pérez-Fernández S; Arana-Arri E; Borrego F
Front Immunol; 2021; 12():655934. PubMed ID: 33777054
[TBL] [Abstract][Full Text] [Related]
15. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
Tomić S; Đokić J; Stevanović D; Ilić N; Gruden-Movsesijan A; Dinić M; Radojević D; Bekić M; Mitrović N; Tomašević R; Mikić D; Stojanović D; Čolić M
Front Immunol; 2021; 12():614599. PubMed ID: 33692788
[TBL] [Abstract][Full Text] [Related]
16. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.
Huang JJ; Gaines SB; Amezcua ML; Lubell TR; Dayan PS; Dale M; Boneparth AD; Hicar MD; Winchester R; Gorelik M
J Allergy Clin Immunol; 2022 Mar; 149(3):912-922. PubMed ID: 34688775
[TBL] [Abstract][Full Text] [Related]
18. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.
Neeland MR; Bannister S; Clifford V; Dohle K; Mulholland K; Sutton P; Curtis N; Steer AC; Burgner DP; Crawford NW; Tosif S; Saffery R
Nat Commun; 2021 Feb; 12(1):1084. PubMed ID: 33597531
[TBL] [Abstract][Full Text] [Related]
19. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
Kvedaraite E; Hertwig L; Sinha I; Ponzetta A; Hed Myrberg I; Lourda M; Dzidic M; Akber M; Klingström J; Folkesson E; Muvva JR; Chen P; Gredmark-Russ S; Brighenti S; Norrby-Teglund A; Eriksson LI; Rooyackers O; Aleman S; Strålin K; Ljunggren HG; Ginhoux F; Björkström NK; Henter JI; Svensson M;
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33479167
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
Borges RC; Hohmann MS; Borghi SM
Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]